TP53 and neoplasm: Combined with the observation that patients with TP53-mutated HNSCC are found in higher proportions among heavy smokers, which has been shown to dampen immune function, these analyses suggest a strong correlation between TP53 mutations and tumor-suppressed immunity in HNSCC.